Fresenius SE Total Long-Term Assets 2016-2024 | FSNUY

Fresenius SE total long-term assets from 2016 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Fresenius SE total long-term assets for the quarter ending June 30, 2024 were $33.998B, a 45.4% decline year-over-year.
  • Fresenius SE total long-term assets for 2023 were $35.46B, a 42.11% decline from 2022.
  • Fresenius SE total long-term assets for 2022 were $61.252B, a 5.01% decline from 2021.
  • Fresenius SE total long-term assets for 2021 were $64.48B, a 10.96% increase from 2020.
Fresenius SE Annual Total Long-Term Assets
(Millions of US $)
2023 $35,460
2022 $61,252
2021 $64,480
2020 $58,113
2019 $57,951
2018 $49,499
2017 $45,810
2016 $38,341
2015 $35,814
Fresenius SE Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $33,998
2024-03-31 $35,767
2023-12-31 $35,460
2023-09-30 $33,189
2023-06-30 $62,271
2023-03-31 $61,668
2022-12-31 $61,252
2022-09-30 $61,323
2022-06-30 $60,972
2022-03-31 $61,847
2021-12-31 $64,480
2021-09-30 $63,378
2021-06-30 $63,563
2021-03-31 $63,020
2020-12-31 $58,113
2020-09-30 $60,189
2020-06-30 $57,699
2020-03-31 $58,063
2019-12-31 $57,951
2019-09-30 $57,356
2019-06-30 $56,288
2019-03-31 $56,821
2018-12-31 $49,499
2018-09-30 $47,822
2018-06-30 $48,533
2018-03-31 $49,282
2017-12-31 $45,810
2017-09-30 $47,279
2017-06-30 $44,104
2017-03-31 $44,057
2016-12-31 $38,341
2016-09-30 $36,451
2016-06-30 $37,075
2016-03-31 $35,149
2015-12-31 $42,942
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00